Skip to main content

Advertisement

Table 3 The values of heart rate (beats/min) in the experimental groups

From: Myocardial protection against global ischemia with Krebs-Henseleit buffer-based cardioplegic solution

Groups Baseline Reperfusion, min
   5 30 60 120
CON-22 (n=7) 243±16 215±21 218±22 238±28 222±35
mKHB-22 (n=7) 253±25 218±32 219±29 246±34 251±28
STH2-22 (n=6) 256±14 227±28 216±22 245±35 236±32
CON-37 (n=7) 250±23 - 187±39 212±52 242±68
mKHB-37 (n=5) 268±21 191±39 195±24 211±32 232±58
STH2-37 (n=6) 269±13 180±35 187±37 223±47 224±12
  1. Data are mean ± SD. Group legends in hypothermia series: controls subjected to 180-min ischemia and 120-min reperfusion (CON-22), cardioplegia with modified Krebs-Henseleit buffer-based cardioplegic solution (mKHB-22), cardioplegia with St Thomas’ Hospital cardioplegic solution №2 (STH2-22). Group legends in normothermia series: controls subjected to 60-min ischemia and 120-min reperfusion (CON-37), cardioplegia with modified Krebs-Henseleit buffer-based cardioplegic solution (mKHB-37), cardioplegia with St Thomas’ Hospital cardioplegic solution №2 (STH2-37).
  2. “-” - persistent ventricular fibrillation/asystole in all hearts.